Friday, October 24, 2014 1:31 AM EST

GlaxoSmithKline

GlaxoSmithKline is the world's fourth largest pharmaceutical company that was formed by the merger of GlaxoWellcome plc and SmithKline Beecham plc.  

It is a research-based company with a wide portfolio of pharmaceutical products covering anti-infectives, central nervous system, respiratory, gastro-intestinal/metabolic, oncology, and vaccines products. It also has a Consumer Healthcare operation comprising leading oral healthcare products, nutritional drinks, and over the counter medicines.

Articles About GlaxoSmithKline

Participants arrive at the opening of a consultation of international experts on potential Ebola therapies and vaccines in Geneva September 4, 2014. On September 4 and 5, the World Health Organization (WHO) will bring together 200 key experts to discuss e
WHO Races to Release Ebola Serum in 2 Weeks, Vaccines in January

By IBTimes AU

The WHO targets to release an Ebola blood serum within two weeks. (6:41 pm)

MORE TOPICS: UNITED KINGDOM, MANUFACTURING, INFECTION

Beware of Ebola-Killer Disease
Ebola Cure News Update: Melbourne Company To Join Global Research For Treatment

By IBTimes AU

A Melbourne company joins international effort for Ebola treatment research (Oct 16)

MORE TOPICS: ALLERGY

An Ebola Virus Treatment Center In Monrovia
No Ebola Vaccine Until Mid-2015: Reasons Why It Is Difficult To Create A Cure Or Vaccine

By IBTimes AU

Vaccines are made to protect humans and animals from severe or life-threatening diseases. (Oct 03)

MORE TOPICS: ALLERGY

Health Workers Prepare To Carry An Abandoned Dead Body Presenting With Ebola Symptoms At Duwala Market In Monrovia
Hoax Alert: 'Ebola Vaccine Only Works on White Skin' Viral Story Not True

By IBTimes AU

A viral story about an Ebola vaccine working only people with white skin is a hoax and should be believed to be true. The source of the story has claimed it is a satire website and everything it publishes is meant for "entertainment purposes. (Sep 29)

A man washes his hands as a preventive measure against the Ebola virus on a street in Monrovia, September 13, 2014. REUTERS/James Giahyue (LIBERIA - Tags: HEALTH SOCIETY)
UK Starts Ebola Vaccine Trials on Humans

By IBTimes AU

A former NHS nurse has become the first volunteer from the U.K. to undertake the Ebola vaccine trial on humans. (Sep 18)

MORE TOPICS: UNITED KINGDOM, UNITED NATIONS, ALLERGY

Workers from Doctors Without Borders unload emergency medical supplies to deal with Ebola
CDC Fears Ebola Virus 'Out of Control'; Human Trials On Third Vaccine To Begin Early 2015

By IBTimes AU

Ebola is feared to be "spiraling out of control" as disease experts and healthcare workers scramble to keep the virus contained. A third vaccine is scheduled to be tested on humans early next year. (Sep 05)

Workers from Doctors Without Borders unload emergency medical supplies to deal with Ebola
Ebola Drug: Human Trial Begins In America

By IBTimes AU

A legally valid Ebola vaccine will be a great relief to those suffering from the disease and can save many lives (Sep 04)

MORE TOPICS: NIGERIA, SENEGAL, MALI, ALLERGY

Health Workers Carry The Body Of An Ebola Virus Victim In Kenema, Sierra Leone
Ebola Outbreak: Vaccine Trials on Humans to Begin Soon, Could Be Marketed By 2015

By IBTimes AU

Clinical tests for possible Ebola vaccine to start in September 2014. (Aug 11)

MORE TOPICS: BARACK OBAMA, INFECTION

Medicines
Forbes Global 2000: Biggest Drug Companies of 2014; Pfizer Tops List

By IBTimes AU

The Forbes Global 2000 ranks annually the top 2,000 public companies in the world as assessed by Forbes magazine on the basis of sales, profit, assets and market value and has been published from 2004 onwards. (Jun 25)

MORE TOPICS: CALIFORNIA, PFIZER, NEW YORK, NEW JERSEY, ANTIBIOTIC, ARTHRITIS, MANUFACTURING, RUSSIA

Rupee Gains on Foreign Fund Inflows

By Reuters

The rupee rose on Friday as foreign funds continued to sell dollars to invest in domestic shares, aided by a risk-on sentiment as a survey showing brisk U.S. manufacturing activity helped lift Asian stocks. (Feb 22)

MORE TOPICS: MANUFACTURING, ELECTIONS